Tech Company Financing Transactions

Myricx Bio Funding Round

Abingworth, Novo Holdings and Brandon Capital Partners joined a $115 million Series A funding round for Myricx Bio. This venture round was announced on 7/8/2024.

Transaction Overview

Company Name
Announced On
7/8/2024
Transaction Type
Venture Equity
Amount
$115,000,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to advance its proprietary pipeline of N-Myristoyltransferase inhibitor (NMTi) ADCs through clinical proof of concept, targeting clinically validated tumor-associated antigens and addressing unmet needs in oncology.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Gridiron Building, 1 Pancras Square, King's Cross
London, N1C 4AG
UK
Phone
Undisclosed
Email Address
Overview
Myricx Bio ("Myricx") is a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer. NMT is an enzyme that adds a specific lipid modification to a number of protein targets key to cancer cell survival.
Profile
Myricx Bio LinkedIn Company Profile
Social Media
Myricx Bio Company Twitter Account
Company News
Myricx Bio News
Facebook
Myricx Bio on Facebook
YouTube
Myricx Bio on YouTube

Management Team

Title
Name
Email & Social
Chairman
Ed Tate
  Ed Tate LinkedIn Profile  Ed Tate Twitter Account  Ed Tate News  Ed Tate on Facebook
Chief Executive Officer
Robin Carr
  Robin Carr LinkedIn Profile  Robin Carr Twitter Account  Robin Carr News  Robin Carr on Facebook
Chief Operating Officer
Julie Mead
  Julie Mead LinkedIn Profile  Julie Mead Twitter Account  Julie Mead News  Julie Mead on Facebook
Chief Scientific Officer
Francesca Zammarchi
  Francesca Zammarchi LinkedIn Profile  Francesca Zammarchi Twitter Account  Francesca Zammarchi News  Francesca Zammarchi on Facebook
Co-Founder
Andrew Bell
  Andrew Bell LinkedIn Profile  Andrew Bell Twitter Account  Andrew Bell News  Andrew Bell on Facebook
Co-Founder
Roberto Solari
  Roberto Solari LinkedIn Profile  Roberto Solari Twitter Account  Roberto Solari News  Roberto Solari on Facebook
Vice President
Robert McLeod
  Robert McLeod LinkedIn Profile  Robert McLeod Twitter Account  Robert McLeod News  Robert McLeod on Facebook
VP - Operations
Nikki D'Arcy
  Nikki D'Arcy LinkedIn Profile  Nikki D'Arcy Twitter Account  Nikki D'Arcy News  Nikki D'Arcy on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/8/2024: Planqc venture capital transaction
Next: 7/8/2024: Flux Marine venture capital transaction

 

Share this article

 


Where The Data Comes From

We record every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary